Video: Intuniv (guanfacine): Introduction and ADHD Overview

An overview of childhood Attention Deficit Disorder Hyperactivity (ADHD) and the non-stimulant treatment Intuniv (guanfacine).

Video Transcript:

Hello and welcome to "VideoScript", presented by Drugs.com.

Today in the first of three presentations, we are reviewing Intuniv, generically known as guanfacine.

Intuniv is an FDA-approved medication used as part of a treatment program to help manage the symptoms of attention deficit hyperactivity disorder, or ADHD. Intuniv is approved for use in children 6 to 17 years of age.

ADHD is a common behavioral disorder diagnosed in roughly 4 to 12 percent of school-aged children. Boys are diagnosed about three times more often than girls.

Treatment of ADHD usually involves some combination of medications, counseling, behavior modification and lifestyle changes. For young children 4 to 5 years of age, parent or teacher-administered behavioral modification is the first treatment of choice.

Patients with ADHD have difficulty maintaining attention and completing tasks, and may show signs of hyperactivity, impulsiveness, or some combination of these behaviors.

Intuniv can be used alone or in combination with stimulants, another class of medications commonly used to treat ADHD. Intuniv comes as an extended-release formulation and is given once daily.

Thank you for joining us at Drugs.com for a brief review of Intuniv. Please refer to our patient and professional information, drug interaction checker, and additional tools on Drugs.com.

Patients with a concern about the use of Intuniv should consult with their health care provider.

Visit drugs.com/Intuniv for more information

+ Expand transcript